HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Clinical trial NCT04153149 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04153149
- Sponsor
- Alnylam Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-26
- Primary completion
- 2024-05-08
- Enrollment
- 655
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.